71 related articles for article (PubMed ID: 11687759)
1. Antithrombotic actions of statins.
Szczeklik A; Undas A; Musial J; Gajewski P; Swadzba J; Jankowski M
Med Sci Monit; 2001; 7(6):1381-5. PubMed ID: 11687759
[TBL] [Abstract][Full Text] [Related]
2. Treatment with simvastatin and low-dose aspirin depresses thrombin generation in patients with coronary heart disease and borderline-high cholesterol levels.
Musiał J; Undas A; Undas R; Brozek J; Szczeklik A
Thromb Haemost; 2001 Feb; 85(2):221-5. PubMed ID: 11246536
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation.
Undas A; Brummel KE; Musial J; Mann KG; Szczeklik A
Circulation; 2001 May; 103(18):2248-53. PubMed ID: 11342472
[TBL] [Abstract][Full Text] [Related]
4. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects.
Puccetti L; Bruni F; Bova G; Cercignani M; Palazzuoli A; Console E; Auteri A; Pasqui AL
Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):378-87. PubMed ID: 12055702
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia.
Szczeklik A; Musiał J; Undas A; Gajewski P; Góra P; Swadźba J; Jankowski M
J Am Coll Cardiol; 1999 Apr; 33(5):1286-93. PubMed ID: 10193729
[TBL] [Abstract][Full Text] [Related]
6. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin administration reduces thromboxane production in subjects taking aspirin: links between aspirin resistance and thrombin generation.
Undas A; Siudak Z; Topór-Mądry R; Leśniak M; Tracz W
Int J Cardiol; 2012 Jan; 154(1):59-64. PubMed ID: 21035882
[TBL] [Abstract][Full Text] [Related]
8. Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia.
Undas A; Celinska-Löwenhoff M; Domagala TB; Iwaniec T; Dropinski J; Löwenhoff T; Szczeklik A
Thromb Haemost; 2005 Jul; 94(1):193-9. PubMed ID: 16113803
[TBL] [Abstract][Full Text] [Related]
9. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
[TBL] [Abstract][Full Text] [Related]
10. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
Malmström RE; Settergren M; Böhm F; Pernow J; Hjemdahl P
Thromb Haemost; 2009 Jan; 101(1):157-64. PubMed ID: 19132203
[TBL] [Abstract][Full Text] [Related]
11. Statins and blood coagulation.
Undas A; Brummel-Ziedins KE; Mann KG
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):287-94. PubMed ID: 15569822
[TBL] [Abstract][Full Text] [Related]
12. [The influence of simvastatin on hsCRP and some paramneters of hemostasis in patients with ischemic heart disease].
Stogowska-Nikiciuk B; Małyszko J; Małyszko JS; Pawlak K; Myśliwiec M
Przegl Lek; 2008; 65(2):68-72. PubMed ID: 18663903
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin reduces endotoxin-induced nuclear factor kappaB activation and mortality in guinea pigs despite lowering circulating low-density lipoprotein cholesterol.
Fraunberger P; Gröne E; Gröne HJ; Walli AK
Shock; 2009 Aug; 32(2):159-63. PubMed ID: 19008785
[TBL] [Abstract][Full Text] [Related]
14. Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin.
Undas A; Stepień E; Branicka A; Wołkow P; Zmudka K; Tracz W
Kardiol Pol; 2009 Jun; 67(6):591-8. PubMed ID: 19618315
[TBL] [Abstract][Full Text] [Related]
15. Blood coagulation at the site of microvascular injury: effects of low-dose aspirin.
Undas A; Brummel K; Musial J; Mann KG; Szczeklik A
Blood; 2001 Oct; 98(8):2423-31. PubMed ID: 11588039
[TBL] [Abstract][Full Text] [Related]
16. Short-term effect of simvastatin treatment on inflammatory parameters in peritoneal dialysis patients.
Sezer MT; Katirci S; Demir M; Erturk J; Adana S; Kaya S
Scand J Urol Nephrol; 2007; 41(5):436-41. PubMed ID: 17853009
[TBL] [Abstract][Full Text] [Related]
17. Different effect induced by treatment with several statins on monocyte tissue factor expression in hypercholesterolemic subjects.
Bruni F; Puccetti L; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Leo A; Auteri A
Clin Exp Med; 2003 May; 3(1):45-53. PubMed ID: 12748879
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin effects in normo- and hypercholesterolaemic patients with peripheral arterial occlusive disease: a pilot study.
Grodzińska L; Starzyk D; Bieroń K; Goszcz A; Korbut R
Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):413-9. PubMed ID: 15910404
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
Sharma R; Mahajan M; Singh B; Bal BS; Kant R
J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
[TBL] [Abstract][Full Text] [Related]
20. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
Borghi C; Dormi A; Veronesi M; Sangiorgi Z; Gaddi A;
Am Heart J; 2004 Aug; 148(2):285-92. PubMed ID: 15308998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]